aminoglutethimide has been researched along with Triple Negative Breast Neoplasms in 1 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arroyo-Crespo, JJ | 1 |
| Armiñán, A | 1 |
| Charbonnier, D | 1 |
| Balzano-Nogueira, L | 1 |
| Huertas-López, F | 1 |
| Martí, C | 1 |
| Tarazona, S | 1 |
| Forteza, J | 1 |
| Conesa, A | 1 |
| Vicent, MJ | 1 |
1 other study available for aminoglutethimide and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment.
Topics: Aminoglutethimide; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Doxorubicin; Dru | 2018 |